Cargando…
Senescent Cells: A Potential Target for New Cancer Therapies in Older Oncologic Patients
Autores principales: | Brattinga, Baukje, van Leeuwen, Barbara L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7828542/ https://www.ncbi.nlm.nih.gov/pubmed/33451087 http://dx.doi.org/10.3390/cancers13020278 |
Ejemplares similares
-
Preoperative Inflammatory Markers as a Predictor of Three-Year Overall Survival in Older Cancer Patients Undergoing Oncologic Surgery
por: Brattinga, Baukje, et al.
Publicado: (2021) -
The association between the inflammatory response following surgery and post-operative delirium in older oncological patients: a prospective cohort study
por: Brattinga, Baukje, et al.
Publicado: (2022) -
Targeting anticancer drug-induced senescence in glioblastoma therapy
por: Tomicic, Maja T., et al.
Publicado: (2018) -
PAI-1: A New Target for Controlling Lung-Cell Senescence and
Fibrosis?
por: Adnot, Serge, et al.
Publicado: (2020) -
Senescent T cells: a potential biomarker and target for cancer therapy
por: Zhang, Jie, et al.
Publicado: (2021)